November 08, 2019
AuroMedics Pharma is recalling a single lot of over-the-counter ranitidine tablets, 150 mg. According to the November 6, 2019, US Food and Drug Administration (FDA) Enforcement Report, some of the bottles are empty.
The recall spans nearly 70,000 bottles of 8-count ranitidine tablets (NDC 55910-092-79) from lot NBSB19001DA3 (Exp. 2/21). The bottles were distributed by Dolgencorp throughout the United States.
AuroMedics Pharma voluntarily initiated the recall September 23, 2019. On October 29, 2019, the FDA designated the recall Class III, signaling use of the product is not likely to cause harm.
Ranitidine is an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.